These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3525087)

  • 1. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of acute otitis media caused by Branhamella catarrhalis. Preliminary report.
    Shurin PA; Van Hare GF
    Drugs; 1986; 31 Suppl 3():122-4. PubMed ID: 3488191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO; Gezelius L
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis.
    Wallace RJ; Steele LC; Brooks DL; Luman JI; Wilson RW; McLarty JW
    Antimicrob Agents Chemother; 1985 Jun; 27(6):912-5. PubMed ID: 3875310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.
    Ninane G; Joly J; Kraytman M; Piot P
    Lancet; 1978 Jul; 2(8083):257. PubMed ID: 79045
    [No Abstract]   [Full Text] [Related]  

  • 7. Augmentin in acute exacerbations of chronic bronchitis.
    Aigner K; Schindl R; Mittermayer H
    J Int Med Res; 1984; 12(6):321-6. PubMed ID: 6335111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of amoxycillin and amoxycillin/clavulanic acid in lower respiratory infections.
    Mehta AP; Phutane L; Patel MH; Rupwate RU; Kamat SR
    J Assoc Physicians India; 1991 Mar; 39(3):251-3. PubMed ID: 1880092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentin (amoxycillin-clavulanic acid) compared with amoxycillin alone in the treatment of urinary tract infections in the elderly.
    Gallacher G; Erwin L; Scott PJ; Sleigh JD
    J Infect; 1986 May; 12(3):229-33. PubMed ID: 3522749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of beta-lactamases in the response of pulmonary infections to amoxycillin/clavulanate.
    Stockley RA; Dragicevic P; Burnett D; Hill SL
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():73-81. PubMed ID: 2606821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):647-9. PubMed ID: 4093205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J; Escoubas J; Fouche J; Mormede M
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
    Cunha BA
    Clin Ther; 1992; 14(3):418-25. PubMed ID: 1638583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.
    Calder MA; Croughan MJ; McLeod DT; Ahmad F
    Drugs; 1986; 31 Suppl 3():11-6. PubMed ID: 3488189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
    Bedenić B; Zagar Z
    J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia.
    Hol C; Van Dijke EE; Verduin CM; Verhoef J; van Dijk H
    J Infect Dis; 1994 Dec; 170(6):1613-6. PubMed ID: 7996007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute otitis media caused by Branhamella catarrhalis: biology and therapy.
    Van Hare GF; Shurin PA; Marchant CD; Cartelli NA; Johnson CE; Fulton D; Carlin S; Kim CH
    Rev Infect Dis; 1987; 9(1):16-27. PubMed ID: 3493519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.